PHASE: A novel approach to pharmacophore modeling and 3D database searching

Chemical Biology and Drug Design

Volumn 67, Issue 5, 2006, Pages 370-372

  Dixon, Steven L ^a   Smondyrev, Alexander M ^a   Rao, Shashidhar N ^a  

^a SCHRÖDINGER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOGEN RECEPTOR ANTAGONIST; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR;

BINDING AFFINITY; DATA BASE; DRUG BINDING; LIGAND BINDING; MODEL; PHARMACOPHORE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; SHORT SURVEY; THREE DIMENSIONAL IMAGING;

BINDING SITES; DATABASES, FACTUAL; KINETICS; LIGANDS; MODELS, MOLECULAR; MOLECULAR CONFORMATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHARMACEUTICAL PREPARATIONS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33745213575     PISSN: 17470277     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1747-0285.2006.00384.x     Document Type: Short Survey

References (7)

1. Keenan R.M. Callahan J.F. Samanen J.M. Bondinell W.E. Calvo R.R. Chen L. DeBrosse C. Eggleston D.S. Haltiwanger R.C. Hwang S.M. Jakas D.R. Ku T.W. Miller W.H. Newlander K.A. Nichols A. Parker M.F. Southhall L.S. Uzinskas I. Vaski-Moser J.A. Venslavsky W. Wong A.S. Huffman W.F. ( 1999) Confirmational Preferences in a Benzodiazepine Series of Potent Nonpeptide Fibrinogen Receptor Antagonists. J Med Chem 42 : 545 559.
2. Sugihara H. Fukushi H. Miyawaki T. Imai Y. Terashita Z. Kawamura M. Fujisawa Y. Kita S. ( 1998) Novel Non-Peptide Fibrinogen Receptor Antagonists. 1. Synthesis and Glycoprotein IIb-IIIa Antagonistic Activities of 1,3,4-Trisubstituted 2-Oxopiperazine Derivatives Incorporating Side-Chain Functions of the RGDF Peptide. J Med Chem 41 : 489 502.
3. Hoekstra W.J. Maryanoff B.E. Damiano B.P. Andrade-Gordon P. Cohen J.H. Costanzo M.J. Haertlein B.J. Hecker L.R. Hulshizer B.L. Kauffman J.A. Keane P. McComsey D.F. Mitchell J.A. Scott L. Shah R.D. Yabut S.C ( 1999) Potent, Orally Active GPIIb/IIIa Antagonists Containing a Nipecotic Acid Subunit. Structure-Activity Studies Leading to the Discovery of RWJ-53308. J Med Chem 42 : 5254 5265.
4. Blackburn B.K. Gadek T.R. ( 1993) Glycoprotein IIbIIIa Antagonists. Ann Rep Med Chem 28 : 79 88.
5. Pierce A.C. Rao G. Bemis G.W. ( 2004) BREED: Generating Novel Inhibitors through Hybridization of Known Ligands. Application to CDK2, P38, and HIV Protease. J Med Chem 47 : 2768 2775.
6. Trejo A. Arzeno H. Browner M. Chanda S. Cheng S. Comer D.D. Dalrymple S.A. Dunten P. LaFargue J. Lovejoy B. Freire-Moar J. Lim J. McIntosh J. Miller J. Papp E. Reuter D. Roberts R. SanPablo F. Saunders J. Song K. Villasenor A. Warren S.D. Welch M. Weller P. Whiteley P.E. Zeng L. Goldstein D.M. ( 2003) Design and Synthesis of 4-Azaindoles as Inhibitors of p38 MAP Kinase. J Med Chem 46 : 4702 4713.
7. Laufer S.A. Zimmermann W. Ruff K.J. ( 2004) Tetrasubstituted Imidazole Inhibitors of Cytokine Release: Probing Substituents in the N-1 Position. J Med Chem 47 : 6311 6325.